Combined Liver-Kidney Transplantation With Preformed Anti–human Leukocyte Antigen Donor-Specific Antibodies

INTRODUCTION: The impact of preformed donor-specific anti–human leukocyte antigen (HLA) antibodies (pDSAs) after combined liver-kidney transplantation (CLKT) is still uncertain. METHODS: We conducted a retrospective study in 8 European high-volume transplant centers and investigated the outcome of 1...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Kidney Int Rep
Autors principals: Del Bello, Arnaud, Thaunat, Olivier, Le Quintrec, Moglie, Bestard, Oriol, Durrbach, Antoine, Perrin, Peggy, Gatault, Philippe, Jambon, Frederic, Pageaux, Georges-Philippe, Llado, Laura, Besch, Camille, Barbier, Louise, Neau-Cransac, Martine, Dumortier, Jérôme, Kamar, Nassim
Format: Artigo
Idioma:Inglês
Publicat: Elsevier 2020
Matèries:
Clinical Research
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7710847/
https://ncbi.nlm.nih.gov/pubmed/33305113
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ekir.2020.09.018
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars